[Clinical study on effect of tuihuan decoction rectoclysis in hyperbilirubinemia of newborn]

Author(s): Duan XF, Bao H, Gong ZZ

Affiliation(s): Rushan Municipal Peoples' Hospital, Shandong. fang.dx@163.com

Publication date & source: 2005-06, Zhongguo Zhong Xi Yi Jie He Za Zhi., 25(6):508-10.

Publication type: Clinical Trial; Randomized Controlled Trial

OBJECTIVE: To study the therapeutic effect and feasibility of rectoclysis with Tuihuang decoction (RTD) in treating hyperbilirubinemia of newborns. METHODS: One hundred and seventy-five newborns with hyperbilirubinemia were randomly divided into the treated group and the control group. They were treated with western medicine plus double faced blue treatment while the treated group were given RTD additionally. Blood bilirubin was detected by micro-bilirubin detector daily during the treatment course. The time of jaundice regression, the speed of blood bilirubin reducing, liver function, and condition of rebounding were observed. RESULTS: The 7-day curative rate of jaundice in the treated group was superior to that in the control group, showing significant difference (P < 0.05). The average speed of blood bilirubin reducing daily in the treated group was quicker than that in the control group (P < 0.01). The improvement of liver function, such as AST, ALT and gamma-GT in the treated group was superior to that in the control group (P < 0.01). Rebound rate of blood bilirubin in the control group was significantly higher than that in the treated group (P < 0.05). CONCLUSION :RTD is an ideal therapy for treatment of hyperbilirubinemia of newborn, it shows obvious clinical efficacy and can effectively prevent the rebound of blood bilirubin.